Canton Hathaway’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-5,000
| Closed | -$729K | – | 264 |
|
|
2022
Q2 | $729K | Sell |
5,000
-860
| -15% | -$125K | 0.25% | 48 |
|
|
2022
Q1 | $695K | Buy |
5,860
+200
| +4% | +$23.7K | 0.19% | 57 |
|
|
2021
Q4 | $780K | Buy |
5,660
+1,160
| +26% | +$160K | 0.21% | 62 |
|
|
2021
Q3 | $625K | Hold |
4,500
| – | – | 0.18% | 73 |
|
|
2021
Q2 | $437K | Hold |
4,500
| – | – | 0.13% | 77 |
|
|
2021
Q1 | $308K | Sell |
4,500
-370
| -8% | -$25.3K | 0.1% | 90 |
|
|
2020
Q4 | $417K | Buy |
4,870
+370
| +8% | +$31.7K | 0.14% | 75 |
|
|
2020
Q3 | $293K | Buy |
4,500
+1,800
| +67% | +$117K | 0.12% | 76 |
|
|
2020
Q2 | $197K | Buy |
+2,700
| New | +$197K | 0.13% | 68 |
|
|
2020
Q1 | – | Sell |
-3,000
| Closed | -$163K | – | 208 |
|
|
2019
Q4 | $163K | Buy |
3,000
+1,000
| +50% | +$54.3K | 0.08% | 91 |
|
|
2019
Q3 | $83K | Buy |
+2,000
| New | +$83K | 0.05% | 106 |
|